|

Validity of the 6-Minute Pegboard and Ring Test in Parkinson's Patients

RECRUITINGSponsored by Emre Şenocak
Actively Recruiting
SponsorEmre Şenocak
Started2024-05-20
Est. completion2024-08-31
Eligibility
Age45 Years – 75 Years
Healthy vol.Accepted

Summary

Tests used to assess upper extremity endurance in Parkinson\'s patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT), which has been validated in many respiratory disease groups in previous studies, is an endurance assessment battery that can also be used in Parkinson\'s patients. 6-MPRT, Weight Lifting Test, and 30-Second Arm Curl Test will be applied in the assessments. Assessments will be made twice on the same day by two different evaluators, 1 hour apart. After the first evaluation, the patient will be called for the second time 2 days later, and the same procedure will be repeated.

Eligibility

Age: 45 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Hoehn \& Yahr staging ≤3 points,
* Individuals who have not undergone a rehabilitation program of at least 20 days in the last 6 months,
* Those with full upper extremity shoulder flexion and abduction active joint range of motion.

Exclusion Criteria:

* Those with severe heart disease such as heart failure, cardiac arrhythmia, hypertension,
* People with any orthopedic problem that will affect the upper extremity,
* Having a secondary neurological disease diagnosis,
* Having vision impairment that may affect measurement methods (not corrected by glasses),
* Having a cognitive disease that may cause difficulty in following the researchers\' commands,
* Those who had changes in their medical use during the test (dose increase/decrease, drug change

Conditions2

Parkinson DiseaseParkinson's Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.